Session Information
IBMS Davos Workshops: Bone Biology & Therapeutics
Click here to go to the previous page
A Randomized, Double-Blind, Placebo-Controlled Study of a Cathepsin-K Inhibitor in the Treatment of Postmenopausal Women with Low BMD: 18-Month Results (126)
Track : Oral Presentations - Bone Therapeutics (A)
Program Code: 170-01
Date: Thursday, March 13, 2008
Time: 11:00 AM to 11:05 AM  EST
Location: Auditorium
AUTHOR (S):
Henry Bone
Carolyn daSilva
Avery Ince, Rahway, USA
Michael McClung
Andrea Rybak-Feiglin
Arthur Santora
Nadia Verbruggen

No items are available for this session.